| Pharmacotherapy for neonatal seizures: current knowledge and future perspectives MD Donovan, BT Griffin, L Kharoshankaya, JF Cryan, GB Boylan Drugs 76 (6), 647-661, 2016 | 110 | 2016 |
| Pharmacokinetic, pharmacodynamic and biodistribution following oral administration of nanocarriers containing peptide and protein drugs BT Griffin, J Guo, E Presas, MD Donovan, MJ Alonso, CM O'Driscoll Advanced Drug Delivery Reviews 106, 367-380, 2016 | 108 | 2016 |
| The effect of organic anion transporter 3 inhibitor probenecid on bumetanide levels in the brain: an integrated in vivo microdialysis study in the rat MD Donovan, FE O'Brien, GB Boylan, JF Cryan, BT Griffin Journal of Pharmacy and Pharmacology 67 (4), 501-510, 2015 | 32 | 2015 |
| Barriers and enablers to deprescribing in long-term care facilities: a ‘best-fit’framework synthesis of the qualitative evidence CH Heinrich, E Hurley, S McCarthy, S McHugh, MD Donovan Age and Ageing 51 (1), afab250, 2022 | 24 | 2022 |
| In vitro bidirectional permeability studies identify pharmacokinetic limitations of NKCC1 inhibitor bumetanide MD Donovan, H Schellekens, GB Boylan, JF Cryan, BT Griffin European journal of pharmacology 770, 117-125, 2016 | 24 | 2016 |
| Assessing community pharmacists’ attitudes towards identifying opportunities for deprescribing in clinical practice in Ireland CH Heinrich, MD Donovan International Journal of Pharmacy Practice 30 (1), 28-35, 2022 | 17 | 2022 |
| Treating disorders of the neonatal central nervous system: pharmacokinetic and pharmacodynamic considerations with a focus on antiepileptics MD Donovan, GB Boylan, DM Murray, JF Cryan, BT Griffin British Journal of Clinical Pharmacology 81 (1), 62-77, 2016 | 14 | 2016 |
| Application of a physiologically‐based pharmacokinetic model for the prediction of bumetanide plasma and brain concentrations in the neonate MD Donovan, K Abduljalil, JF Cryan, GB Boylan, BT Griffin Biopharmaceutics & Drug Disposition 39 (3), 125-134, 2018 | 13 | 2018 |
| The P-glycoprotein inhibitor cyclosporin A differentially influences behavioural and neurochemical responses to the antidepressant escitalopram FE O’Brien, RM O’Connor, G Clarke, MD Donovan, TG Dinan, BT Griffin, ... Behavioural brain research 261, 17-25, 2014 | 12 | 2014 |
| Barriers and enablers to deprescribing in long-term care: A qualitative investigation into the opinions of healthcare professionals in Ireland CH Heinrich, S McHugh, S McCarthy, MD Donovan PLoS One 17 (12), e0274552, 2022 | 11 | 2022 |
| Identification of potentially inappropriate medications in frail older adults residing in long-term care: a retrospective chart review study CH Heinrich, S McCarthy, S McHugh, MD Donovan Drugs-Real World Outcomes 10 (1), 97-106, 2023 | 8 | 2023 |
| Perspectives of pharmacists on facilitating experiential learning placements for pharmacy students in non-patient facing settings MD Donovan, EM Byrne, BT Griffin Currents in Pharmacy Teaching and Learning 12 (8), 901-909, 2020 | 6 | 2020 |
| Multidisciplinary DEprescribing review for Frail oldER adults in long-term care (DEFERAL): Implementation strategy design using behaviour science tools and stakeholder engagement CH Heinrich, S McHugh, S McCarthy, GM Curran, MD Donovan Research in Social and Administrative Pharmacy 19 (8), 1202-1213, 2023 | 5 | 2023 |
| The prevalence of and documented indications for antipsychotic prescribing in irish nursing homes JE Kelleher, P Weedle, MD Donovan Pharmacy 9 (4), 160, 2021 | 5 | 2021 |
| Barriers and enablers to deprescribing in long-term care facilities: A qualitative investigation into the opinions of healthcare professionals in ireland CH Heinrich, S McHugh, S McCarthy, MD Donovan PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 31, 20-21, 2022 | 2 | 2022 |
| The impact of Aβ and tau on prospective cognitive decline in older individuals RA Sperling, EC Mormino, AP Schultz, RA Betensky, KV Papp, ... Ann. Neurol 85, 0 | 1 | |
| Feasibility study of a multidisciplinary DEprescribing review for Frail oldER Adults in Long-term care (DEFERAL) targeting potentially inappropriate antihypertensive medications CH Heinrich, S McCarthy, S McHugh, ER Shanahan, MD Donovan International Journal of Pharmacy Practice 32 (Supplement_1), i16-i17, 2024 | | 2024 |
| A survey on the perspectives of Irish pharmacists on the implementation of pharmacogenetics into pharmacy practice E Cooney, M Donovan International Journal of Pharmacy Practice 32 (Supplement_1), i60-i61, 2024 | | 2024 |
| 5PSQ-003 Improving medicines management of inpatient Parkinson’s disease patients by making pharmacy interventions M Knipe, E Conyard, M Donovan European Journal of Hospital Pharmacy 31 (Suppl 1), A164-A164, 2024 | | 2024 |
| 76 Improving medicines management of inpatient Parkinson’s Disease patients by making pharmacy interventions M Knipe, E Conyard, M Donovan Age and Ageing 52 (Supplement_3), afad156. 095, 2023 | | 2023 |